Journal Name: Endocrinology and Diabetes Open Access
ISSN: 2631-374X
DOI: 10.31021
Indexing: Click Here
Journal Type: Open Access
Contact Us: Click Here
Endocrinology and Diabetes Open Access (EDOA) is an international, peer-reviewed, open access journal published by Boffin Access Limited, dedicated to advancing research, clinical practice, and innovation in endocrinology, metabolism, and diabetes care. The journal provides a global platform for endocrinologists, diabetologists, researchers, and healthcare professionals to publish high-quality scientific findings that address the complexities of hormonal disorders and diabetes management.
With the global rise in metabolic diseases, EDOA emphasizes both basic and clinical research to promote early diagnosis, effective treatment, and innovative therapeutic strategies that improve patient outcomes and public health.
Endocrinology and Diabetes Open Access publishes original research articles, reviews, case reports, short communications, and clinical studies covering a broad range of topics, including but not limited to:
Pathophysiology and management of type 1 and type 2 diabetes
Endocrine disorders: thyroid, adrenal, pituitary, and gonadal dysfunctions
Insulin resistance, obesity, and metabolic syndrome
Advances in diabetes technology: continuous glucose monitoring, insulin pumps, and digital health solutions
Hormonal regulation of growth, reproduction, and metabolism
Endocrine oncology: thyroid, adrenal, and pituitary tumors
Pediatric endocrinology and juvenile diabetes
Nutrition, lifestyle interventions, and preventive strategies
Innovative therapies: stem cell research, gene therapy, and regenerative medicine in endocrinology
Public health approaches to diabetes and metabolic diseases
Global Relevance – Addresses urgent worldwide challenges in endocrinology, diabetes, and metabolism.
Rigorous Peer Review – Ensures all submissions are evaluated fairly for scientific merit and ethical compliance.
Wide Readership – Open access publishing guarantees visibility to clinicians, researchers, educators, and policymakers across the globe.
Rapid Publication – Accepted manuscripts are published online within weeks, ensuring timely access to new findings.
Multidisciplinary Focus – Bridges endocrinology, clinical medicine, nutrition, pharmacology, and biotechnology.
Author-Centric Policy – Authors retain copyright under Creative Commons licensing, maximizing visibility and citation.
Enhanced Formats – Articles available in PDF, HTML, and supplementary formats including datasets, infographics, and clinical images.
EDOA strictly follows COPE and ICMJE guidelines to maintain transparency, accountability, and academic integrity. Clinical studies require ethical approval, and informed patient consent is mandatory for case reports.
SCINEXI is committed to upholding the integrity and credibility of the scholarly record. In accordance with international publishing ethics, articles may be retracted when found to contain serious errors, evidence of research misconduct, copyright infringement, or plagiarism. Retraction is a necessary step to safeguard academic reliability and to ensure that the literature remains a trustworthy resource for the global research community.
If you wish to report a concern regarding any published article, please share the details with us by clicking below:
Send Information
Stay connected with SCINEXI. Enter your e-mail address to receive alerts on newly published articles, special issue announcements, and the latest updates from our journals.
At SCINEXI, we actively welcome feedback and constructive criticism. Your compliments, concerns, and suggestions help us refine our services and elevate the author and reader experience.
Have an idea that could advance the Open Access community? We’d love to hear it. Please write to: support@scinexi.com
Copyright © 2025 BOFFIN ACCESS.